Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) ClinicalTrials.gov, 2 Nov 2015 Accessed on 17 Mar 2016 from https://clinicaltrials.gov/ct2/show/NCT02419378. CommentRecommendBookmarkWatch